Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct:192:69-73.
doi: 10.1016/j.urology.2024.06.048. Epub 2024 Jun 25.

Scrotal Cancer Incidence Rates and Trends-United States, 1999-2020

Jacqueline M Mix  1 , Sameer V Gopalani  2 , Maureen Miller  3 , Mona Saraiya  4 , Teresa M Darragh  5 , Charles F Lynch  6 , Trevor D Thompson  4 , Virginia Senkomago  4 , April Greek  7 , Thomas C Tucker  8 , Elizabeth R Unger  4
Affiliations

Scrotal Cancer Incidence Rates and Trends-United States, 1999-2020

Jacqueline M Mix et al. Urology. 2024 Oct.

Abstract

Objective: To examine population-level scrotal cancer incidence rates and trends among adult men in the United States.

Methods: Data from the United States Cancer Statistics, covering approximately 96% of the United States population, were analyzed to calculate age-standardized incidence rates of scrotal cancer among men aged 18 years and older from 1999 to 2020. Trends in incidence rates were evaluated by age, race and ethnicity, Census region, and histology using joinpoint regression.

Results: Overall, 4669 men were diagnosed with scrotal cancer (0.20 per 100,000). Incidence rates were highest among men aged 70 years and older (0.82 per 100,000). Rates were higher among non-Hispanic Asian or Pacific Islander men (0.31 per 100,000) compared to other race and ethnicity groups. The most common histologic subtypes were squamous cell carcinoma (35.9%), extramammary Paget disease (20.8%), and sarcoma (20.5%). Incidence rates decreased by 2.9% per year from 1999 to 2019 for non-Hispanic Asian or Pacific Islander men, decreased by 8.1% per year from 1999 to 2006 for basal cell carcinomas, and increased by 1.8% per year from 1999 to 2019 for extramammary Paget disease; otherwise, rates remained stable for all other variables examined.

Conclusion: While scrotal cancer incidence rates were higher than previously reported, rates were still low and stable over time.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Vyas R, Zargar H, Trolio RD, Di Lorenzo G, Autorino R. Squamous cell carcinoma of the scrotum: A look beyond the chimneystacks. World J Clin Cases. Nov 16 2014;2(11):654–60. doi:10.12998/wjcc.v2.i11.654 - DOI - PMC - PubMed
    1. Wright JL, Morgan TM, Lin DW. Primary scrotal cancer: disease characteristics and increasing incidence. Urology. Nov 2008;72(5):1139–43. doi:10.1016/j.urology.2008.06.043 - DOI - PubMed
    1. Verhoeven RH, Louwman WJ, Koldewijn EL, Demeyere TB, Coebergh JW. Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989. Br J Cancer. Oct 26 2010;103(9):1462–6. doi:10.1038/sj.bjc.6605914 - DOI - PMC - PubMed
    1. Guimerà N, Alemany L, Halec G, et al. Human papillomavirus 16 is an aetiological factor of scrotal cancer. Br J Cancer. Apr 25 2017;116(9):1218–1222. doi:10.1038/bjc.2017.74 - DOI - PMC - PubMed
    1. Mix JM, Miller MJ, Querec TD, Darragh TM, Saraiya M, Gopalani SV, Lynch CF, Thompson TD, Greek A, Tucker TC, Peters ES, Unger ER. Human Papillomavirus Detection in Scrotal Squamous Cell Carcinoma: Case Series from a Population-Based Cancer Registry. J Registry Manag. 2023. Winter;50(4):116–121. . - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources